सभी अध्ययन
भर्तीप्रेक्षणीय

SOT प्राप्तकर्ताओं और HSCT रोगियों में गैंसिक्लोविर प्रतिरोधी/प्रतिरोधी साइटोमेगालोवायरस संक्रमण

This study, called ReCySOHT, is looking back at the medical records of adults who have had a solid organ transplant (like a kidney or heart transplant) or a blood stem cell transplant. We're focusing on patients who developed a Cytomegalovirus (CMV) infection that didn't respond well to ganciclovir, a standard medicine. Doctors want to understand why some people get this type of CMV infection and what factors might increase their risk. By looking at information from many patients, the study hopes to find common patterns. The goal is to help healthcare teams better prevent and treat these challenging CMV infections, ultimately improving care for transplant recipients.

एक नजर में

स्थिति
भर्ती
प्रायोजक
IRCCS Azienda Ospedaliero-Universitaria di Bologna
नामांकन लक्ष्य
100
प्रारंभ
19 जून 2023
अनुमानित पूर्णता
28 Feb 2028

यह अध्ययन किस बारे में है?

When you have an organ transplant or a stem cell transplant, your immune system is often weaker to prevent your body from rejecting the new organ or cells. This can make you more vulnerable to infections, like Cytomegalovirus, or CMV. CMV is a common virus that can cause serious problems for transplant patients.

Usually, doctors use a medicine called ganciclovir to treat or prevent CMV infections. It's generally very effective and safe. However, sometimes the CMV infection doesn't respond to ganciclovir, either because the virus becomes resistant to the drug, or it just doesn't clear up. This is called ganciclovir-resistant or refractory (GCV-RR) CMV, and it can be a serious problem because there are fewer treatment options, and they can have more side effects. It's important for doctors to understand why this happens and who might be at higher risk.

This study is looking back at information from many transplant patients to gather more details about these specific CMV infections. By carefully reviewing existing medical records, researchers hope to identify common factors or situations that lead to ganciclovir-resistant CMV. This knowledge will be crucial for developing better ways to prevent these difficult infections and improve treatment strategies for patients in the future.

मुख्य निष्कर्ष

  • Study examines past medical records of transplant patients.
  • Focuses on a difficult-to-treat CMV infection (ganciclovir-resistant).
  • Aims to find risk factors for this type of infection.
  • No new treatments or tests for participants.
  • Information gained could improve future patient care.
  • Your data will be anonymous and confidential.

कौन पात्र हो सकता है?

To be included in this study, you would be an adult, aged 18 or older, who has received either a solid organ transplant (like a kidney, heart, or liver) or a blood (stem cell) transplant. You would also have experienced a CMV infection that was treated with specific medicines called ganciclovir or valganciclovir.

Because this is a study looking at past medical records, researchers need to be able to find certain information in your charts. For example, they need to know details about your transplant, like if there was a good match between your body and the donor, and how you recovered after both your CMV infection and your transplant.

You wouldn't be part of this study if some of this important medical information is missing from your records, as researchers wouldn't be able to get a complete picture of your situation. For instance, if they can't find clear notes about your CMV infection, details about the donor match, or how you were doing 30, 60, or 90 days after your CMV was diagnosed, then you wouldn't be included.

क्या यह अध्ययन आपके लिए उपयुक्त हो सकता है?

यह देखने के लिए इन त्वरित प्रश्नों का उत्तर दें कि क्या आप पात्र हो सकते हैं। यह केवल एक मार्गदर्शिका है — अंतिम निर्णय शोध टीम द्वारा लिया जाता है।.

  1. क्या आप 18 वर्ष या उससे अधिक आयु के हैं?
  2. Have you had an organ or stem cell transplant?
  3. Did you get a CMV infection after your transplant?
  4. Was your CMV infection treated with ganciclovir or valganciclovir?
  5. Are your medical records complete regarding your transplant and CMV treatment?
अपने परिणाम देखने के लिए हर प्रश्न का उत्तर दें।.

भागीदारी में क्या शामिल है?

This study is a bit different because it's a "retrospective observational study." This means researchers are looking back at information that has already been collected in your past medical records. You won't need to attend any extra appointments, take new medicines, or undergo any additional tests. Your participation simply involves allowing the research team to review your existing health information to help them learn more about CMV infections in transplant patients. There are no direct visits or follow-up actions required from you.

संभावित जोखिम और लाभ

Since this study only involves looking at existing medical records, there are no physical risks or direct benefits to you as a participant. Your medical care will not change in any way. The potential benefit is to future patients; the information gathered from your anonymised data, combined with that of others, could help doctors better prevent and treat difficult CMV infections in transplant recipients. You have the right to withdraw your consent for your data to be used at any time without affecting your medical treatment.

स्थान (23)

  • एमडी एंडरसन कैंसर केंद्र
    सत्यापित पोस्टकोड
    ह्यूस्टन, संयुक्त राज्य अमेरिका· अभी भर्ती नहीं हो रही है
  • Institut Jules Bordet
    सत्यापित पोस्टकोड
    ब्रुसेल्स, बेल्जियम· अभी भर्ती नहीं हो रही है
  • University Hospitals Leuven
    सत्यापित पोस्टकोड
    ल्यूवेन, बेल्जियम· अभी भर्ती नहीं हो रही है
  • Helsinki University Central Hospital
    सत्यापित पोस्टकोड
    हेलसिंकी, फिनलैंड· अभी भर्ती नहीं हो रही है
  • Centre Hospitalier Universitaire de Limoges
    सत्यापित पोस्टकोड
    Limoges, France· अभी भर्ती नहीं हो रही है
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    सत्यापित पोस्टकोड
    बोलोग्ना, इटली· भर्ती
  • Humanitas Research Hospital
    सत्यापित पोस्टकोड
    Rozzano, Italy· अभी भर्ती नहीं हो रही है
  • Istituto mediterraneo per i trapianti e terapie ad alta specializzazione (ISMETT)
    सत्यापित पोस्टकोड
    Palermo, Italy· भर्ती
  • Ospedale San Martino
    सत्यापित पोस्टकोड
    जेनोवा, इटली· अभी भर्ती नहीं हो रही है
  • Policlinico di Milano
    सत्यापित पोस्टकोड
    मिलान, इटली· भर्ती
  • Azienda Ospedaliero-Universitaria di Modena
    सत्यापित पोस्टकोड
    Modena, Italy· भर्ती
  • Azienda Ospedaliera dei Colli
    सत्यापित पोस्टकोड
    नेपल्स, इटली· अभी भर्ती नहीं हो रही है

सामान्य प्रश्न

What is CMV and why is it important for transplant patients?

CMV is a common virus that can cause serious illness in people with weakened immune systems, such as those who have received an organ or stem cell transplant.

What does 'ganciclovir-resistant' mean?

It means the CMV infection didn't respond well to ganciclovir, a standard medicine usually used to treat it, making the infection harder to clear.

Will this study affect my current medical care?

No, this study only looks at past medical records. It will not change your current or future medical care in any way.

क्या मेरी व्यक्तिगत जानकारी गोपनीय रखी जाती है?

Yes, all data collected for the study will be treated confidentially, and your personal details will be anonymised to protect your privacy.

Who is conducting this study?

The ReCySOHT study is being conducted by multiple medical centres, aiming to gather a broad range of information on CMV infections.

और अधिक जानने के लिए कैसे पता करें

Renato Pascale, MD

किसी अध्ययन में भाग लेने का निर्णय लेने से पहले हमेशा अपने जीपी या विशेषज्ञ से बात करें।.

भाग लेने में रुचि रखते हैं?

अपनी रुचि दर्ज करें

अपने विवरण साझा करें और अनुसंधान टीम के लिए "Ganciclovir Resistant/Refractory Cytomegalovirus Infection i…यदि आप पात्र हो सकते हैं तो आपसे संपर्क करेंगे। भाग लेने के लिए सहमति देने से पहले हमेशा अपने जीपी से बात करें।.

चर्चा

समुदाय चर्चा

हमारे फोरम द्वारा संचालित community.patient.info. कृपया सम्मानजनक रहें — यह चिकित्सा सलाह नहीं है।.